Beyond Cholesterol
Franklin H. Epstein, Daniel I. Steinberg, Sampath Parthasarathy et al. · New England Journal of Medicine · 1989
IT is now well established that hypercholesterolemia is an important cause of coronary heart disease, and clinical intervention studies have demonstrated the therapeutic value of correcting hypercholesterolemia.1 , 2 The National Cholesterol Education Program has been instituted on the basis of these findings.3 From that ambitious program we can anticipate the development of progressively better methods of reducing plasma cholesterol levels and therefore even further decreases in mortality from coronary heart disease. However, no matter how successfully we deal with hypercholesterolemia, coronary heart disease will not disappear, because a high cholesterol level is by no means the only causative factor. At any . . .
Cited by 6,427 works. doi:10.1056/nejm198904063201407
Authors
- Franklin H. Epstein
- Daniel I. Steinberg
- Sampath Parthasarathy
- Thomas E. Carew
- John C. Khoo
- Joseph Lee Witztum
References
- The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
- Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
- The Pathogenesis of Atherosclerosis
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
- LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
- Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
- Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.
- Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.
- Low density lipoprotein undergoes oxidative modification in vivo.